However, there are still further studies that can be carried out in the future to explore whether the content of the MAP3K9 gene products taken from samples such as blood and bile from HCC patients could differ those taken from the normal population, as data for these media were not available in the present study. The gene discussed is MAP3K9; the disease is hepatocellular carcinoma.